Envoy Medical (COCHW) Return on Equity (2021 - 2026)

Envoy Medical's Return on Equity history runs 6 years deep, the most recent figure standing at 0.24% for Q1 2026.

• In Q1 2026, Return on Equity rose 23.0% year-over-year to 0.24%; the TTM figure through Mar 2026 stood at 0.24% (up 23.0% YoY), while the FY2025 annual figure was 0.02%, changed 0.0% from the prior year.
• Return on Equity came in at 0.24% for Q1 2026 at Envoy Medical, up from 0.02% in the prior quarter.
• In the past five years, Return on Equity ranged from a high of 0.24% in Q1 2026 to a low of 0.07% in Q4 2023.
• A 5-year average of 0.02% and a median of 0.01% in 2025 frame the typical range for Return on Equity.
• Across the five-year window, Return on Equity slipped 6 bps in 2023 and increased 23 bps in 2026, its largest moves.
• Envoy Medical's Return on Equity stood at 0.01% in 2022, then tumbled by 1004 bps to 0.07% in 2023, then soared by 115 bps to 0.01% in 2024, then surged by 124 bps to 0.02% in 2025, then surged by 907 bps to 0.24% in 2026.
• According to Business Quant data, Return on Equity over the past three periods registered 0.24%, 0.02%, and 0.01% for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison